- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/335 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 207/335
Total number of patents in this class: 143
10-year publication summary
11
|
7
|
9
|
8
|
13
|
6
|
8
|
4
|
7
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bayer Pharma AG | 1053 |
8 |
Daiichi Sankyo Company, Limited | 1877 |
5 |
Synact Pharma ApS | 22 |
5 |
Arena Pharmaceuticals, Inc. | 365 |
4 |
Grey Wolf Therapeutics Limited | 16 |
4 |
Janssen Pharmaceutica N.V. | 3394 |
3 |
Sumitomo Chemical Company, Limited | 9043 |
3 |
Shanghai Leado PharmaTech Co. Ltd. | 16 |
3 |
Bristol-myers Squibb Company | 4880 |
2 |
FUJIFILM Corporation | 29437 |
2 |
Applied Materials, Inc. | 18746 |
2 |
Konica Minolta, Inc. | 8755 |
2 |
Mitsui Chemicals, Inc. | 3222 |
2 |
BIAL - Portela & CA, S.A. | 222 |
2 |
Biocon Limited | 219 |
2 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 188 |
2 |
Dainippon Sumitomo Pharma Co., Ltd. | 194 |
2 |
Exelixis, Inc. | 400 |
2 |
Nippon Zoki Pharmaceutical Co., Ltd. | 142 |
2 |
North Carolina State University | 1562 |
2 |
Other owners | 84 |